VIT-7L-188

N/A

Report date: 2025/06/11 11:08:45
NME

Base Information

Drug NameVIT-7L-188
Drug Alias Nameanti-angiopoietin-2 aptamers (Vitrisa Therapeutics)VIT-7L-204VIT-7L-188
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionAngiopoietin-2 inhibitors
TargetsAngiopoietin-2
Therapy Area/IndicationsRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVitrisa Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVitrisa Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRetinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A